Finnish Academy Fellow and the leader of the Neurometabolomics group at Turku Bioscience Centre, University of Turku. He is also the head of the Turku Centre for Chemical and Molecular Analytics (CCMA), Department of Chemistry and the Co-PI and founder of the Turku Metabolomics Centre with Matej Orešič. He obtained his DPhil from the University of Oxford in 2013 where he utilized NMR based metabolomics to prognose different brain diseases from blood. He then completed two post-doctoral research positions. First in the Turku PET Centre, where he was investigating new tracers for neuroinflammation. Secondly, he went to Johns Hopkins School of Medicine where he identified a new mechanism of how the brain communicates to the periphery via extra cellular vesicles. He also established new MS based lipidomic methods. He then joined the Orešič group in Turku. His current research group focuses on developing new MS based methods for the detection of a wide range of metabolites and then applying these to see metabolism changes following brain injury or development. It particularly focuses on how the endocannabinoid system can act as long range signaling molecules between the brain and periphery.
